Diet-induced alteration of fatty acid synthase in prostate cancer progression

Oncogenesis

Volumn 5, Issue , 2016, Pages

  Huang, M ^a,b   Koizumi, A ^a,b   Narita, S ^a,b   Inoue, T ^a,b   Tsuchiya, N ^a   Nakanishi, H ^a   Numakura, K ^a   Tsuruta, H ^a   Saito, M ^a   Satoh, S ^a   Nanjo, H ^a   Sasaki, T ^a,b   Habuchi, T ^a,b  

^a AKITA UNIVERSITY   (Japan)

^b JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ADENYLATE KINASE; DOCETAXEL; ESTRAMUSTINE PHOSPHATE; FATTY ACID SYNTHASE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANDROGEN DEPRIVATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; DIET; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84959530109     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2015.42     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA 2007; 57: 43-66.
2. Ito K. Prostate cancer in Asian men. Nat Rev Urol 2014; 11: 197-212.
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.
4. Blair A, Fraumeni JF. Geographic patterns of prostate cancer in the United States. J Natl Cancer Inst 1978; 61: 1379-1384.
5. Narita S, Tsuchiya N, Saito M, Inoue T, Kumazawa T, Yuasa T et al. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis. Prostate 2008; 68: 321-335.
6. Huang M, Narita S, Numakura K, Tsuruta H, Saito M, Inoue T et al. A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling. Prostate 2012; 72: 1779-1788.
7. Venkateswaran V, Klotz LH. Diet and prostate cancer: mechanisms of action and implications for chemoprevention. Nat Rev Urol 2010; 7: 442-453.
8. Zadra G, Priolo C, Patnaik A, Loda M. New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK. Clin Cancer Res 2010; 16: 3322-3328.
9. Tsukamoto Y, Wong H, Mattick JS, Wakil SJ. The architecture of the animal fatty acid synthetase complex. IV. Mapping of active centers and model for the mechanism of action. J Biol Chem 1983; 258: 15312-15322.
10. Schweizer M, Roder K, Zhang L, Wolf SS. Transcription factors acting on the promoter of the rat fatty acid synthase gene. Biochem Soc Trans 2002; 30: 1070-1072.
11. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-777.
12. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res 1997; 57: 1086-1090.
13. Swinnen JV, Ulrix W, Heyns W, Verhoeven G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 1997; 94: 12975-12980.
14. Vande Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 2002; 62: 642-646.
15. Baba Y, Nosho K, Shima K, Meyerhardt JA, Chan AT, Engelman JA et al. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer. Br J Cancer 2010; 103: 1025-1033.
16. Pandey V, Vijayakumar MV, Ajay AK, Malvi P, Bhat MK. Diet-induced obesity increases melanoma progression: involvement of Cav-1 and FASN. Int J Cancer 2012; 130: 497-508.
17. Xiao R, Su Y, Simmen RC, Simmen FA. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase. Am J Physiol Gastrointest Liver Physiol 2008; 294: G868-G876.
18. Moore RG, Lange TS, Robinson K, Kim KK, Uzun A, Horan TC et al. Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. PLoS ONE 2012; 7: e34443.
19. Puig T, Relat J, Marrero PF, Haro D, Brunet J, Colomer R. Green tea catechin inhibits fatty acid synthase without stimulating carnitine palmitoyltransferase-1 or inducing weight loss in experimental animals. Anticancer Res 2008; 28: 3671-3676.
20. Wang YY, Kuhajda FP, Li J, Finch TT, Cheng P, Koh C et al. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer. J Exp Ther Oncol 2004; 4: 101-110.
21. Wang YY, Kuhajda FP, Cheng P, Chee WY, Li T, Helzlsouer KJ et al. A new model ELISA, based on two monoclonal antibodies, for quantification of fatty acid synthase. J Immunoassay Immunochem 2002; 23: 279-292.
22. Wang Y, Kuhajda FP, Li JN, Pizer ES, Han WF, Sokoll LJ et al. Fatty acid synthase (FAS) expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett 2001; 167: 99-104.
23. Vazquez-Martin A, Fernandez-Real JM, Oliveras-Ferraros C, Navarrete JM, Martin-Castillo B, Del Barco S et al. Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Int J Oncol 2009; 35: 1369-1376.
24. Fernandez-Real JM, Menendez JA, Moreno-Navarrete JM, Bluher M, Vazquez-Martin A, Vazquez MJ et al. Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes 2010; 59: 1506-1511.
25. Kuhajda FP. AMP-activated protein kinase and human cancer: cancer metabolism revisited. Int J Obes (Lond) 2008; 32 (Suppl 4): S36-S41.
26. Oliveras-Ferraros C, Vazquez-Martin A, Fernandez-Real JM, Menendez JA. AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid Synthase. Biochem Biophys Res Commun 2009; 378: 488-493.
27. Tang FY, Pai MH, Chiang EP. Consumption of high-fat diet induces tumor progression and epithelial-mesenchymal transition of colorectal cancer in a mouse xenograft model. J Nutr Biochem 2012; 23: 1302-1313.
28. Migita T, Ruiz S, Fornari A, Fiorentino M, Priolo C, Zadra G et al. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 2009; 101: 519-532.
29. Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 2004; 64: 2212-2221.
30. Chakravarty B, Gu Z, Chirala SS, Wakil SJ, Quiocho FA. Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain. Proc Natl Acad Sci USA 2004; 101: 15567-15572.
31. Maier T, Leibundgut M, Ban N. The crystal structure of a mammalian fatty acid synthase. Science 2008; 321: 1315-1322.
32. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LW. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 1994; 57: 406-412.
33. Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, Obara T et al. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Carcinogenesis 2011; 32: 1589-1596.